Literature DB >> 6209170

Ultrastructural localization of monoamines and peptides in rat area postrema.

V M Pickel, D M Armstrong.   

Abstract

An overall schema for the synaptic interactions of monoaminergic and peptidergic neurons and their relation to the ventricle and to blood vessels within the rat area postrema is presented. The specific markers include: 1) the immunocytochemical localization of the catecholamine-synthesizing enzyme tyrosine hydroxylase, and the neuropeptides enkephalin and substance P; and 2) the radioautographic localization of [3H]serotonin (5-hydroxytryptamine) and 3H-labeled amino acids anterogradely transported from the nodose ganglion.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6209170

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  6 in total

Review 1.  Pharmacological Agents Affecting Emesis : A Review (Part II).

Authors:  F Mitchelson
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

2.  Distribution of alpha 2-adrenergic binding sites in the parabrachial complex of the rat.

Authors:  H Herbert; G Flügge
Journal:  Anat Embryol (Berl)       Date:  1995-12

3.  Inhibition of cisplatin-induced vomiting by selective 5-hydroxytryptamine M-receptor antagonism.

Authors:  W D Miner; G J Sanger
Journal:  Br J Pharmacol       Date:  1986-07       Impact factor: 8.739

4.  5-HT3 receptor antagonists injected into the area postrema inhibit cisplatin-induced emesis in the ferret.

Authors:  G A Higgins; G J Kilpatrick; K T Bunce; B J Jones; M B Tyers
Journal:  Br J Pharmacol       Date:  1989-05       Impact factor: 8.739

Review 5.  Chemotherapy induced emesis--mechanisms and treatment: a review.

Authors:  C M Edwards
Journal:  J R Soc Med       Date:  1988-11       Impact factor: 18.000

Review 6.  A History of Drug Discovery for Treatment of Nausea and Vomiting and the Implications for Future Research.

Authors:  Gareth J Sanger; Paul L R Andrews
Journal:  Front Pharmacol       Date:  2018-09-04       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.